Karen Williamson

630 total citations
10 papers, 544 citations indexed

About

Karen Williamson is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Karen Williamson has authored 10 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in Karen Williamson's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Karen Williamson is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Karen Williamson collaborates with scholars based in United States, Switzerland and Belgium. Karen Williamson's co-authors include Jean‐Michel Dayer, A Cruchaud, P Seckinger, Jean-François Balavoine, William G. Rice, Mark A. Payton, Alan Shaw, Keith Rose, M G Simona and Paul T. Wingfield and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Karen Williamson

10 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Williamson United States 9 186 180 124 94 84 10 544
Michael Westby United Kingdom 13 180 1.0× 289 1.6× 93 0.8× 106 1.1× 47 0.6× 18 596
Marianna Dioszegi United States 10 244 1.3× 134 0.7× 119 1.0× 201 2.1× 24 0.3× 12 572
Paul Feucht United States 9 215 1.2× 214 1.2× 68 0.5× 44 0.5× 80 1.0× 11 597
R Carlisle United States 8 204 1.1× 63 0.3× 239 1.9× 178 1.9× 30 0.4× 12 516
Janet L. Paulsen United States 14 223 1.2× 69 0.4× 135 1.1× 68 0.7× 75 0.9× 16 437
Zufan Debebe United States 12 327 1.8× 191 1.1× 116 0.9× 128 1.4× 17 0.2× 17 823
Paul L. Black United States 13 141 0.8× 153 0.8× 79 0.6× 65 0.7× 25 0.3× 27 467
Terrence W. Brann United States 11 365 2.0× 253 1.4× 120 1.0× 88 0.9× 16 0.2× 16 713
Patricia DeLora United States 8 92 0.5× 45 0.3× 155 1.3× 128 1.4× 31 0.4× 9 350
Ralph Abraham United States 8 141 0.8× 91 0.5× 102 0.8× 107 1.1× 35 0.4× 17 395

Countries citing papers authored by Karen Williamson

Since Specialization
Citations

This map shows the geographic impact of Karen Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Williamson more than expected).

Fields of papers citing papers by Karen Williamson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Williamson. The network helps show where Karen Williamson may publish in the future.

Co-authorship network of co-authors of Karen Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Williamson. A scholar is included among the top collaborators of Karen Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Williamson. Karen Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cushman, Mark, Jeffrey A. Ruell, Erik De Clercq, et al.. (1999). Extension of the Polyanionic Cosalane Pharmacophore as a Strategy for Increasing Anti-HIV Potency. Journal of Medicinal Chemistry. 42(10). 1767–1777. 14 indexed citations
2.
Neamati, Nouri, Jim A. Turpin, John L. Christensen, et al.. (1999). Thiazolothiazepine Inhibitors of HIV-1 Integrase. Journal of Medicinal Chemistry. 42(17). 3334–3341. 77 indexed citations
3.
Cushman, Mark, Agustin Casimiro‐Garcia, Karen Williamson, & William G. Rice. (1998). Synthesis of a non-nucleoside reverse transcriptase inhibitor in the alkenyldiarylmethane (ADAM) series with optimized potency and therapeutic index. Bioorganic & Medicinal Chemistry Letters. 8(2). 195–198. 16 indexed citations
4.
Cushman, Mark, Agustin Casimiro‐Garcia, Elżbieta Hejchman, et al.. (1998). New Alkenyldiarylmethanes with Enhanced Potencies as Anti-HIV Agents Which Act as Non-Nucleoside Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 41(12). 2076–2089. 30 indexed citations
5.
Cushman, Mary, Agustin Casimiro‐Garcia, Elżbieta Hejchman, et al.. (1998). ChemInform Abstract: New Alkenyldiarylmethanes with Enhanced Potencies as anti‐HIV Agents which Act as Non‐Nucleoside Reverse Transcriptase Inhibitors.. ChemInform. 29(39). 3 indexed citations
6.
Turpin, Jim A., Robert W. Buckheit, David Derse, et al.. (1998). Inhibition of Acute-, Latent-, and Chronic-Phase Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Bistriazoloacridone Analog That Selectively Inhibits HIV-1 Transcription. Antimicrobial Agents and Chemotherapy. 42(3). 487–494. 44 indexed citations
7.
Balavoine, Jean-François, et al.. (1986). Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).. Journal of Clinical Investigation. 78(4). 1120–1124. 167 indexed citations
8.
Wingfield, Paul T., Mark A. Payton, Alan Shaw, et al.. (1986). Purification and characterization of human interleukin‐1β expressed in recombinant Escherichia coli. European Journal of Biochemistry. 160(3). 491–497. 144 indexed citations
9.
Fareed, Jawed, Jeanine M. Walenga, Karen Williamson, et al.. (1985). Studies on the Antithrombotic Effects and Pharmacokinetics of Heparin Fractions and Fragments. Seminars in Thrombosis and Hemostasis. 11(1). 56–74. 37 indexed citations
10.
Fareed, J., et al.. (1984). Antithrombotic actions and pharmacokinetics of heparin fractions and fragments.. PubMed. 26(4). 267–75. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026